FDA Approved: TAFINLAR — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for TAFINLAR (dabrafenib) submitted by Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• TAFINLAR (DABRAFENIB)

Snippet

SUPPL AP for TAFINLAR (DABRAFENIB)